InflaRx N.V. (IFRX)
NASDAQ: IFRX · Real-Time Price · USD
1.400
+0.180 (14.75%)
Oct 24, 2025, 4:00 PM EDT - Market closed
InflaRx Market Cap
InflaRx has a market cap or net worth of $94.85 million as of October 24, 2025. Its market cap has increased by 8.83% in one year.
Market Cap
94.85M
Enterprise Value
39.18M
1-Year Change
8.83%
Ranking
Category
Stock Price
$1.40
Market Cap Chart
Since November 8, 2017, InflaRx's market cap has decreased from $351.36M to $94.85M, a decrease of -73.01%. That is a compound annual growth rate of -15.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 24, 2025 | 94.85M | -34.79% |
| Dec 31, 2024 | 145.44M | 51.53% |
| Dec 29, 2023 | 95.98M | -29.96% |
| Dec 30, 2022 | 137.03M | -34.85% |
| Dec 31, 2021 | 210.33M | 48.13% |
| Dec 31, 2020 | 141.99M | 37.35% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Nov 8, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 744.31B |
| Johnson & Johnson | 457.33B |
| AbbVie | 401.33B |
| UnitedHealth Group | 328.63B |
| AstraZeneca | 258.15B |
| Novartis AG | 254.23B |
| Novo Nordisk | 236.86B |
| Abbott Laboratories | 221.61B |